Abstract
Pembrolizumab, a programmed cell death protein 1 (PD1) inhibitor inhibits the interplay between PD1 of T-cell and programmed cell death ligand 1 (PDL1) on tumor cells. Although pembrolizumab has been tried to various subtypes of non-Hodgkin lymphoma (NHL), realworld data about the efficacy of pembrolizumab in NHL patients are limited. We analyzed the outcome of 30 relapsed or refractory NHL patients treated with pembrolizumab, and compared the outcome between Epstein-Barr virus (EBV)‒positive and negative subtypes because EBV infection of tumor cells can upregulate PDL1 expression. Seven patients with EBV-positive NHL showed a response including NK/T-cell lymphoma (6/14, 44%) and primary mediastinal B-cell lymphoma (1/4, 25%) whereas EBV-negative subtypes did not respond such as diffuse large B-cell lymphoma and T-lymphoblastic lymphoma. We also evaluated PDL1 expression using tumor tissue of 76 patients. High PDL1 expression (positive staining of > 50% of tumor cells) was more frequent in NK/T-cell lymphoma and primary mediastinal B-cell lymphoma than other subtypes. Thus, PDL1 expression was significantly higher in EBV-positive (18/32, 56%) than EBV-negative NHL (4/38, 11%, p < 0.001). Furthermore, NK/T-cell lymphoma patients...Continue Reading
References
Nov 16, 2010·Seminars in Oncology·Jeffrey Weber
Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivien MakKerry J Savage
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Feb 6, 2014·Blood·David D W TwaChristian Steidl
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Aug 5, 2015·Blood·Junichi KiyasuKoichi Ohshima
Dec 22, 2015·The Lancet. Haematology·Seok Jin KimUNKNOWN Asia Lymphoma Study Group
Dec 25, 2015·Blood·Bjoern ChapuyMargaret A Shipp
Apr 6, 2016·Human Pathology·Thomas MenterAlexandar Tzankov
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaretha G M RoemerMargaret A Shipp
Jun 23, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Charlotte RoachKarina Kulangara
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philippe ArmandCraig H Moskowitz
Jul 31, 2016·Annals of Hematology·Thomas S Y ChanYok-Lam Kwong
Jul 31, 2016·Annals of Hematology·Thomas S Y ChanYok-Lam Kwong
Aug 31, 2016·Blood·Bruce D ChesonPhilippe Armand
Oct 28, 2016·Virchows Archiv : an International Journal of Pathology·Wook Youn KimYoon Kyung Jeon
Oct 4, 2016·Annals of Hematology·Jae-Cheol JoHee Jeong Cha
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Nov 20, 2016·PloS One·Semir VranicZoran Gatalica
Dec 15, 2016·Hematological Oncology·Marion FourVanessa Szablewski
Feb 1, 2017·Annals of Hematology·Thomas S Y ChanYok-Lam Kwong
Feb 12, 2017·Blood·Yok-Lam KwongEric Tse
Apr 21, 2017·Blood·Wei DingStephen M Ansell
Apr 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert ChenUNKNOWN KEYNOTE-087
May 12, 2017·Blood·Pier Luigi ZinzaniPhilippe Armand
Jul 30, 2017·BMC Cancer·Jianping LaiAnwen Liu
Aug 5, 2017·Blood·Michael CrumpChristian Gisselbrecht
Citations
Feb 20, 2020·American Journal of Hematology·Brady E BeltranJorge J Castillo
Mar 13, 2020·Blood·Nader Kim El-Mallawany, Kenneth L McClain
Oct 28, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Junhun ChoWon Seog Kim
May 1, 2020·Leukemia & Lymphoma·Yeong Eun KimHo Joon Im
Jul 20, 2020·Journal of Neuro-oncology·Leon D KaulenJoachim M Baehring
Sep 13, 2020·Cancers·Yonggang PeiErle S Robertson
Jun 12, 2019·Journal of Hematology & Oncology·Peipei GaoPeng Wu
May 12, 2020·Frontiers in Oncology·Yue SongMingzhi Zhang
Aug 6, 2020·International Journal of Molecular Sciences·Ayumi KuzumeYosuke Minami
Jan 10, 2020·Blood Advances·Matthew J FrigaultRobin M Joyce
Aug 14, 2020·Journal of Hematology & Oncology·Basit SalikKyohei Nakamura
Dec 4, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Danielle L V MaracajaMina L Xu
Dec 3, 2020·Vaccines·Robert PytlikPavel Klener
Aug 9, 2020·Blood·Seok Jin KimWon Seog Kim
Oct 31, 2020·International Journal of Molecular Sciences·Ji-Yoon NohHaiyoung Jung
Oct 27, 2020·Frontiers in Oncology·Polina ShindiapinaRobert A Baiocchi
Dec 29, 2020·Frontiers in Oncology·Zheng YanZhihua Yao
Feb 11, 2021·Journal of Oncology·Guang-Liang ChenJunning Cao
Feb 26, 2021·OncoTargets and Therapy·Yang FuZhen-Yu Ding
Feb 23, 2021·Frontiers in Pharmacology·Lee S NguyenJoe-Elie Salem
Mar 20, 2021·Current Stem Cell Reports·Sandhya SharmaHelen E Heslop
Apr 20, 2021·La Revue de médecine interne·Y DieudonneA Guffroy
Jun 3, 2021·Cells·Joshua W D TobinColm Keane
Jun 13, 2021·Leukemia·Hua WangYang Liang
Apr 9, 2021·Histopathology·Emad AbabnehGenevieve M Crane
Jul 26, 2021·Annals of Hematology·Won Seog KimHelen E Heslop
Oct 29, 2021·International Journal of Laboratory Hematology·Lingyue XuHongzai Guan